My HPRA: Register

Summary of Direct Healthcare Professional Communications (DHPCs) issued in January 2019

News Category: 3rd party

Date: 04/02/2019

 Please find below the links to all Direct Healthcare Professional Communications (DHPCs) issued in January 2019

18.01.2019
Medicinal products containing carbimazole or thiamazole - Important Safety Info from Amdipharm Limited and Essential-Healthcare Ltd as approved by the HPRA

22.01.2019
Sodium-Glucose-Co-Transporter 2 inhibitors (SGLT2i) - Important Safety Information from marketing authorisation holders of products containing SGLT2 inhibitors as approved by the HPRA

31.01.2019
Lartruvo (olaratumab) - Important Safety Information from Eli Lilly & Company as approved by the HPRA

« Back